1.Analysis of Medical Use and Treatment Costs of Hepatocellular Carcinoma Patients Using National Patient Sample Data
Byeong-Chan OH ; Jeong-Yeon CHO ; Sun-Hong KWON ; Eui-Kyung LEE ; Hye-Lin KIM
Korean Journal of Clinical Pharmacy 2021;31(2):153-159
Background:
With increasing economic evaluation studies on the treatment of or screening tools for liver diseases that cause hepatocellular carcinoma (HCC), interest in the analysis of the medical utilization and costs of HCC treatment is increasing. Therefore, we aimed to estimate the medical utilization and costs of HCC patients, and calculate the cost of main procedures for HCC treatment, including liver transplant (LT), hepatic resection (HR), radiofrequency ablation (RFA), and transarterial chemoembolization (TACE).
Methods:
We analyzed claim data from January to December 2018 from the Health Insurance and Review and Assessment Service–National Patient Sample (HIRA-NPS-2018) dataset, including data of patients diagnosed with HCC (Korean Standard Classification of Diseases code C22.0) who had at least one inpatient claim for HCC.
Results:
A total of 715 HCC patients were identified. In 2018, the yearly average medical cost per HCC patient was ₩18,460K (thousand), of which ₩14,870K was attributed to HCC. Among the total medical costs of HCC patients, the inpatient cost accounted for the largest portion of both the total medical and HCC-related costs. The major procedures of HCC treatment occurred most frequently in the order of TACE, RFA, HR, and LT. The average medical cost per treatment episode was the highest for LT (₩87,280K), followed by HR (₩10,026K), TACE (₩4,047K), and RFA (₩2,927K).
Conclusion
By identifying the medical costs of HCC patients and the costs of the main procedures of HCC treatment, our results provide basic information that could be utilized for cost estimation in liver disease-related economic evaluation studies.
2.Analysis of Medical Use and Treatment Costs of Hepatocellular Carcinoma Patients Using National Patient Sample Data
Byeong-Chan OH ; Jeong-Yeon CHO ; Sun-Hong KWON ; Eui-Kyung LEE ; Hye-Lin KIM
Korean Journal of Clinical Pharmacy 2021;31(2):153-159
Background:
With increasing economic evaluation studies on the treatment of or screening tools for liver diseases that cause hepatocellular carcinoma (HCC), interest in the analysis of the medical utilization and costs of HCC treatment is increasing. Therefore, we aimed to estimate the medical utilization and costs of HCC patients, and calculate the cost of main procedures for HCC treatment, including liver transplant (LT), hepatic resection (HR), radiofrequency ablation (RFA), and transarterial chemoembolization (TACE).
Methods:
We analyzed claim data from January to December 2018 from the Health Insurance and Review and Assessment Service–National Patient Sample (HIRA-NPS-2018) dataset, including data of patients diagnosed with HCC (Korean Standard Classification of Diseases code C22.0) who had at least one inpatient claim for HCC.
Results:
A total of 715 HCC patients were identified. In 2018, the yearly average medical cost per HCC patient was ₩18,460K (thousand), of which ₩14,870K was attributed to HCC. Among the total medical costs of HCC patients, the inpatient cost accounted for the largest portion of both the total medical and HCC-related costs. The major procedures of HCC treatment occurred most frequently in the order of TACE, RFA, HR, and LT. The average medical cost per treatment episode was the highest for LT (₩87,280K), followed by HR (₩10,026K), TACE (₩4,047K), and RFA (₩2,927K).
Conclusion
By identifying the medical costs of HCC patients and the costs of the main procedures of HCC treatment, our results provide basic information that could be utilized for cost estimation in liver disease-related economic evaluation studies.
3.A Case of Histiocytic Sarcoma Presenting with Primary Bone Marrow Involvement.
Byeong Seok SOHN ; Tark KIM ; Jeong Eun KIM ; Eunsin BAE ; Chan Jeoung PARK ; Jooryung HUH ; Sang Oh LEE
Journal of Korean Medical Science 2010;25(2):313-316
Histiocytic sarcoma (HS) is a very rare neoplasm that often shows an aggressive clinical course and systemic symptoms, such as fever, weight loss, adenopathy, hepatosplenomegaly and pancytopenia. It may present as localized or disseminated disease. We describe here a 63-yr-old male who manifested systemic symptoms, including fever, weight loss and generalized weakness. Abdominal and chest computed tomography failed to show specific findings, but there was suspicion of multiple bony changes at the lumbar spine. Fusion whole body positron emission tomography, bone scan and lumbar spine magnetic resonance imaging showed multiple bone lesions, suggesting a malignancy involving the bone marrow (BM). Several BM and bone biopsies were inconclusive for diagnosis. Necropsy showed replacement of the BM by a diffuse proliferation of neoplastic cells with markedly increased cellularity (95%). The neoplastic cells were positive for lysozyme and CD68, but negative for T- and B-cell lineage markers, and megakaryocytic, epithelial, muscular and melanocytic markers. Morphologic findings also distinguished it from other dendritic cell neoplasms.
Antigens, CD/metabolism
;
Antigens, Differentiation, Myelomonocytic/metabolism
;
Bone Marrow/metabolism/pathology
;
Bone Marrow Neoplasms/*diagnosis/pathology
;
Diagnosis, Differential
;
Histiocytic Sarcoma/*diagnosis/pathology
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Muramidase/metabolism
;
Positron-Emission Tomography
;
Tomography, X-Ray Computed
4.A case of the surgical treatment for deep vein thrombosis in the leg caused by huge uterine adenomyosis.
In Seock JANG ; Jong Hyeon KIM ; Tai gun IM ; Kyoung Ho AHN ; Jeoung Heon LEE ; You Sung LEE ; Kwan Sik KIM ; Byeong Chan OH
Korean Journal of Obstetrics and Gynecology 2001;44(12):2320-2324
Uterine adenomyosis is a common benign pelvic tumor in women. One of the complications that may be infrequently associated with the huge pelvic mass is venous stasis of the lower extremities and may develop thrombophlebitis secondary to pelvic compression. Intravascular thrombosis in the deep vein of the legs is a serious illness that sometimes cause death due to acute pulmonary thromboembolism. Deep vein thrombosis (DVT) has been reported to be closely related to pregnancy, surgical procedure, long term bedrest, obesity, and oral contraceptives. However, there is few report about deep vein thrombosis caused by huge uterine adenomyosisWe report a case of deep vein thrombosis caused by huge adenomyosis was treated by hysterectomy, thrombectomy, and thrombolysis with a brief review of the literature.
Adenomyosis*
;
Bed Rest
;
Contraceptives, Oral
;
Female
;
Humans
;
Hysterectomy
;
Leg*
;
Lower Extremity
;
Obesity
;
Pregnancy
;
Pulmonary Embolism
;
Thrombectomy
;
Thrombophlebitis
;
Thrombosis
;
Veins
;
Venous Thrombosis*
5.Facile Fabrication of Animal-Specific Positioning Molds For Multi-modality Molecular Imaging.
Jeong Chan PARK ; Jieun OH ; Seungtae WOO ; Wonjung KWAK ; Jeong Eun LEE ; Kyeong Min KIM ; Gwang Il AN ; Tae Hyun CHOI ; Gi Jeong CHEON ; Youngmin CHANG ; Sang Woo LEE ; Byeong Cheol AHN ; Jaetae LEE ; Jeongsoo YOO
Nuclear Medicine and Molecular Imaging 2008;42(5):401-409
PURPOSE: Recently multi-modal imaging system has become widely adopted in molecular imaging. We tried to fabricate animal-specific positioning molds for PET/MR fusion imaging using easily available molding clay and rapid foam. The animal-specific positioning molds provide immobilization and reproducible positioning of small animal. Herein, we have compared fiber-based molding clay with rapid foam in fabricating the molds of experimental animal. MATERIALS AND METHODS: The round bottomed-acrylic frame, which fitted into microPET gantry, was prepared at first. The experimental mice was anesthetized and placed on the mold for positioning. Rapid foam and fiber-based clay were used to fabricate the mold. In case of both rapid foam and the clay, the experimental animal needs to be pushed down smoothly into the mold for positioning. However, after the mouse was removed, the fabricated clay needed to be dried completely at 60 degrees C in oven overnight for hardening. Four sealed pipet tips containing [18F]FDG solution were used as fiduciary markers. After injection of [18F]FDG via tail vein, microPET scanning was performed. Successively, MRI scanning was followed in the same animal. RESULTS: Animal-specific positioning molds were fabricated using rapid foam and fiber-based molding clay for multimodality imaging. Functional and anatomical images were obtained with microPET and MRI, respectively. The fused PET/MR images were obtained using freely available AMIDE program. CONCLUSION: Animal-specific molds were successfully prepared using easily available rapid foam, molding clay and disposable pipet tips. Thanks to animal-specific molds, fusion images of PET and MR were co-registered with negligible misalignment.
Aluminum Silicates
;
Animals
;
Fungi
;
Immobilization
;
Magnetic Resonance Imaging
;
Mice
;
Molecular Imaging
;
Veins
6.Evaluation of a competitive ELISA for antibody detection against avian influenza virus.
Dae Sub SONG ; Youn Jeong LEE ; Ok Mi JEONG ; Yong Joo KIM ; Chan Hee PARK ; Jung Eun YOO ; Woo Jin JEON ; Jun Hun KWON ; Gun Woo HA ; Bo Kyu KANG ; Chul Seung LEE ; Hye Kwon KIM ; Byeong Yeal JUNG ; Jae Hong KIM ; Jin Sik OH
Journal of Veterinary Science 2009;10(4):323-329
Active serologic surveillance is necessary to control the spread of the avian influenza virus (AIV). In this study, we evaluated a commercially-available cELISA in terms of its ability to detect AIV antibodies in the sera of 3,358 animals from twelve species. cELISA detected antibodies against reference H1- through H15-subtype AIV strains without cross reactivity. Furthermore, the cELISA was able to detect antibodies produced following a challenge of the AIV H9N2 subtype in chickens, or following vaccination of the AIV H9 or H5 subtypes in chickens, ducks and geese. Next, we tested the sensitivity and specificity of the cELISA with sera from twelve different animal species, and compared these results with those obtained by the hemagglutination-inhibition (HI) test, the "gold standard" in AIV sera surveillance, a second commercially-available cELISA (IZS ELISA), or the agar gel precipitation (AGP) test. Compared with the HI test, the sensitivities and specificities of cELISA were 95% and 96% in chicken, 86% and 88% in duck, 97% and 100% in turkey, 100% and 87% in goose, and 91% and 97% in swine, respectively. The sensitivities and specificities of the cELISA in this study were higher than those of IZS ELISA for the duck, turkey, goose, and grey partridge sera samples. The results of AGP test against duck and turkey sera also showed significant correlation with the results of cELISA (R-value >0.9). In terms of flock sensitivity, the cELISA correlated better with the HI test than with commercially-available indirect ELISAs, with 100% flock sensitivity.
Animals
;
Antibodies, Viral/*blood
;
Birds
;
Enzyme-Linked Immunosorbent Assay/methods/*veterinary
;
Horses
;
Influenza A virus/*immunology
;
Influenza Vaccines/immunology
;
Influenza in Birds/blood/*immunology/prevention & control
;
Sensitivity and Specificity
;
Serologic Tests
;
Species Specificity
;
Swine
7.A Case of Collagenous Colitis Following the Prolonged Use of Non-steroidal anti-inflammatory Drugs (NSAIDs).
Sun Hi MOON ; Chan Gyoo KIM ; Jun Oh JUNG ; You Sun KIM ; Jin Hyok HWANG ; Seon Mie KIM ; Byeong Gwan KIM ; Dong Young PARK ; Woon Tae JEONG ; Dong Ho LEE ; Hyun Chae JUNG ; In Sung SONG ; Gyu Wan CHOI ; Chung Yong KIM
Korean Journal of Medicine 1997;53(4):586-590
Collagenous colitis is characterized clinically by chronic watery diarrhea and pathologically by increased subepithelial collagen deposition associated with an inflammatory infiltrate in the lamina propria. Its etiology is still unclear, although a variety of associated diseases such as rheumatic syndromes, scleroderma, and thyroid diseases have been reported. We report a case of collagenous colitis following the prolonged use of NSAIDs. A 72-year-old woman who has taken NSAIDs for many years due to some dermatologic problems was admitted to the hospital because of chronic watery diarrhea and colicky abdominal pain of 3 months duration. There was no abnormal physical finding except cachectic appearance due to weight loss of 10kg during 3 months. Stool examination for ova and parasites and fat was negative, and stool culture for bacterial pathogens was negative. In complete blood count, there were relative eosinophila and mild anemia. Total serum protein and albumin was low, and thyroid function, RA factor, FANA were all normal. Results of upper and lower gastrointestinal contrast radiographs were normal. Sigmoidoscopy revealed normal colonic mucosa but she had a thick subepithelial collagenous deposit and chronic inflammation in lamina propria on colonic biopsy. Based on the above findings, she was diagnosed as collagenous colitis. Diarrhea improved after withdrawing NSAIDs and the treatment with oral prednisolone. In the post-treatment biopsy, the thickness of the collagen hand was diminished. Collagenous colitis is now recognized as one of the common causes of chronic diarrhea of obscure origin and NSAIDs may play an etiological role in some patient with collagenous colitis.
Abdominal Pain
;
Aged
;
Anemia
;
Anti-Inflammatory Agents, Non-Steroidal
;
Biopsy
;
Blood Cell Count
;
Colitis, Collagenous*
;
Collagen*
;
Colon
;
Diarrhea
;
Female
;
Hand
;
Humans
;
Inflammation
;
Mucous Membrane
;
Ovum
;
Parasites
;
Prednisolone
;
Sigmoidoscopy
;
Thyroid Diseases
;
Thyroid Gland
;
Weight Loss
8.Basic Facts of Breast Cancer in Korea in 2014: The 10-Year Overall Survival Progress.
Eun Hwa PARK ; Sun Young MIN ; Zisun KIM ; Chan Seok YOON ; Kyu Won JUNG ; Seok Jin NAM ; Se Jeong OH ; Seeyoun LEE ; Byeong Woo PARK ; Woosung LIM ; Min Hee HUR
Journal of Breast Cancer 2017;20(1):1-11
We, the Korean Breast Cancer Society (KBCS), present the facts and the trends of breast cancer in Korea in 2014. Data on the total number of newly diagnosed patients was obtained from the Korea Central Cancer Registry database, other data were collected from the KBCS online registry database, and the overall survival data of patients were updated from Statistics Korea. A total of 21,484 female patients were newly diagnosed with breast cancer in 2014. The crude incidence rate and the age-standardized incidence rate (ASR) of breast cancer in female patients, including carcinoma in situ, were 83.4 cases and 63.9 cases per 100,000 women, respectively. The ASR showed an annual increase of 6.1% from 1999 to 2014; however, although the increase of the ASR had slowed since 2008, the incidence rate itself continuously increased. The proportion of early breast cancer increased consistently, and the pathological features changed accordingly. While breast-conserving surgery was mainly performed, the proportion of total mastectomy was slightly increased. The total number of breast reconstruction surgeries increased rapidly. The 5-year and 10-year overall survival rates for all stages of breast cancer patients were 91.2% and 84.8%, respectively. The overall survival rate of Korean patients with breast cancer was extremely high, compared with other developed countries. Thus, we consider that the clinical characteristics of breast cancer have changed over the past decade. A nationwide registry data will contribute to a better understanding of the characteristics of breast cancer in Korea.
Breast Neoplasms*
;
Breast*
;
Carcinoma in Situ
;
Developed Countries
;
Female
;
Humans
;
Incidence
;
Korea*
;
Mammaplasty
;
Mastectomy, Segmental
;
Mastectomy, Simple
;
Online Systems
;
Registries
;
Survival Rate